{"id":"W4289937561","doi":"10.1097/01.cot.0000856128.09599.bc","title":"Dabrafenib + Trametinib in BRAF V600-Mutant Pediatric Low-Grade Glioma","year":2022,"lang":"en","type":"article","venue":"Oncology Times","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Trametinib; Dabrafenib; Mutant; Glioma; Cancer research; Medicine; Oncology; Biology; Melanoma; Genetics; Gene; Kinase; MAPK/ERK pathway; Metastatic melanoma; Vemurafenib","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004165092,0.0002562758,0.0004747332,0.0001551051,0.0001436327,0.0002673023,0.0001525397,0.0002451078,0.0008395119],"category_scores_gemma":[0.0005412163,0.00009778233,0.0005750012,0.0003165606,0.0001291732,0.0002464887,0.000139057,0.0007903316,0.0001208944],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001046901,"about_ca_system_score_gemma":0.0008388266,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00620494,"about_ca_topic_score_gemma":0.02062052,"domain_scores_codex":[0.9998335,0.00007755753,0.00001326672,0.00001699385,0.00002516438,0.00003354881],"domain_scores_gemma":[0.999821,0.00004466506,0.00003339966,0.000006848655,0.00001877241,0.00007531736],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.06374558,0.002775063,0.07666327,0.001838479,0.00148891,0.003410234,0.0003910774,0.002765731,0.01645934,0.00137094,0.03980089,0.7892906],"study_design_scores_gemma":[0.09098455,0.1747375,0.4654794,0.001114772,0.006838411,0.01893298,0.001317782,0.00632757,0.02919587,0.001863032,0.2031044,0.0001035907],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9364246,0.0481431,0.0004506426,0.008613051,0.0004837743,0.000135777,0.0005265773,0.00006620496,0.005156217],"genre_scores_gemma":[0.9731163,0.02157121,0.0009374069,0.001792052,0.0002518567,0.00009503472,0.0004600348,0.00001142768,0.001764813],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00620494,"threshold_uncertainty_score":0.01233763,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01618388823420492,"score_gpt":0.2961422827599354,"score_spread":0.2799583945257305,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}